Aptevo Therapeutics Inc
(APVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 6,024 | 6,983 | 6,383 | 6,561 | 8,178 |
| Operating Income | -6,024 | -6,983 | -6,383 | -6,561 | -8,178 |
| Other Income | 141 | 149 | 188 | 227 | 230 |
| Pre-tax Income | -5,883 | -6,834 | -6,195 | -6,334 | -7,948 |
| Net Income Continuous | -5,883 | -6,834 | -6,195 | -6,334 | -7,948 |
| Net Income Discontinuous | N/A | N/A | 293 | N/A | N/A |
| Net Income | $-5,883 | $-6,834 | $-5,902 | $-6,334 | $-7,948 |
| EPS Basic Total Ops | -22,247.48 | -132,449.60 | -67,960.94 | -288,812.40 | -703,133.20 |
| EPS Basic Continuous Ops | -22,247.55 | -132,450.10 | -49,981.81 | -288,812.40 | -703,133.20 |
| EPS Basic Discontinuous Ops | N/A | N/A | -17,946.65 | N/A | N/A |
| EPS Diluted Total Ops | -22,247.48 | -132,449.60 | -67,960.94 | -288,812.40 | -703,133.20 |
| EPS Diluted Continuous Ops | -22,247.55 | -132,450.10 | -49,981.81 | -288,812.40 | -703,133.20 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -17,946.65 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -21,765.20 | -129,678.90 | N/A | N/A | N/A |
| EBITDA(a) | $-5,933 | $-6,877 | $-6,267 | $-6,438 | $-8,028 |